Keyphrases
Vasoactive Intestinal Peptide
100%
Activity-dependent Neuroprotective Protein
90%
Alzheimer's Disease
35%
Neuroprotection
34%
Microtubules
31%
Activity-dependent
27%
Neurotrophic Factors
23%
Davunetide
23%
Tubulin
22%
NAPVSIPQ
21%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
19%
Drug Candidates
17%
Neuroprotective
15%
Autism
15%
Tauopathy
15%
Amino Acids
14%
Neuroprotective Peptide
13%
Neuropeptides
13%
Femtomolar
12%
Vasoactive Intestinal Peptide Receptor 1
10%
Astrocytes
10%
Progressive Supranuclear Palsy
9%
Gene Expression
9%
Vasoactive Intestinal Polypeptide
8%
Messenger RNA (mRNA)
8%
Neuronal Survival
8%
Peptide Antagonist
8%
Rat Brain
7%
Mouse Model
7%
Neurodegenerative Diseases
7%
Oxidative Stress
7%
Tau Hyperphosphorylation
7%
Neurite Outgrowth
7%
Receptor Antagonist
7%
Drug Development
7%
Neurotoxicity
6%
End-binding Proteins
6%
Neurodegeneration
6%
Neuroprotective Activity
6%
Peptide Analogs
6%
Neuroprotective Drugs
6%
Factor 9
6%
Tau Pathology
6%
Schizophrenia Symptoms
6%
Brain Formation
6%
Clinical Trials
6%
Peptide Drugs
6%
Schizophrenia
6%
SALLRSIPA
5%
Protein Expression
5%
Neuroscience
Neuroprotective Agent
97%
Vasoactive Intestinal Peptide
89%
Microtubule
31%
Alzheimer's Disease
29%
Neuroprotection
28%
Neurotrophic Factor
21%
Tubulin
19%
Pervasive Developmental Disorder
17%
Astrocyte
14%
Amino Acid
12%
Dementia Praecox
12%
Hypophysis Adenylate Cyclase Activating Polypeptide
11%
Neuropeptide
11%
Behavior (Neuroscience)
11%
Tauopathy
10%
Gene Expression
10%
Amyloid
9%
In Vivo
9%
Cyclic Adenosine Monophosphate
8%
In Vitro
8%
Oxidative Stress
7%
Neurodegenerative Disorder
7%
Protein Binding
6%
Protein Expression
6%
Closed Head Injury
6%
Nerve Cell Differentiation
5%
Neurite Outgrowth
5%
Factor IX
5%
Hyperphosphorylation
5%
Nervous System
5%
Neuroblastoma
5%
Axoplasmic Transport
5%
Neurodegeneration
5%
Water Maze
5%
Adenylyl Cyclase
5%
